Form 8-K - Current report:
SEC Accession No. 0001104659-25-017774
Filing Date
2025-02-27
Accepted
2025-02-27 07:08:55
Documents
15
Period of Report
2025-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm257621d1_8k.htm   iXBRL 8-K 27445
2 EXHIBIT 99.1 tm257621d1_ex99-1.htm EX-99.1 258001
6 GRAPHIC tm257621d1_ex99-1img001.jpg GRAPHIC 22648
  Complete submission text file 0001104659-25-017774.txt   518837

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA irwd-20250227.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20250227_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20250227_pre.xml EX-101.PRE 22371
17 EXTRACTED XBRL INSTANCE DOCUMENT tm257621d1_8k_htm.xml XML 3686
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 25672966
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)